
High-value medical information should be available wherever patients seek care. Today a syndromic panel returns a routine, confident result in the hospital and almost nowhere else. Bringing that same result to decentralized care is the core mission of VedaBio.
A test earns its place in urgent care only by meeting every requirement of that setting. These are the specifications VedaBio is being designed to meet.
A result that arrives after the patient has gone home lands in the chart and misses the decision it was ordered for. The answer needs to arrive in minutes, while the patient is still in the room.
The panel should include the targets that can change an ambulatory patient’s treatment, chosen for the urgent-care population it serves.
No molecular bench, no technologist on shift, no separate workflow. Collect, load, read.
Economics that work at clinic volumes, so the decision to test is never the hard part of the visit.

Fewer prescriptions written on impression, fewer return visits, and a patient who leaves knowing what they have.